Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6190)
All Articles published online
|
Publishing Process of This Article
|
Apr 7, 2015 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang YQ, Guo JS. Antiviral therapies for hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol 2015; 21(13): 3860-3866 [PMID: 25852270 DOI: 10.3748/wjg.v21.i13.3860] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v21/i13/3860.htm |
| Number | Citing Articles |
| 1 |
Zhikai Zheng, Jiongliang Wang, Tianqing Wu, Minrui He, Juncheng Wang, Yangxun Pan, Jinbin Chen, Dandan Hu, Li Xu, Yaojun Zhang, Minshan Chen, Zhongguo Zhou. Tenofovir versus Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma After FOLFOX-Hepatic Arterial Infusion Chemotherapy. Journal of Hepatocellular Carcinoma 2023; : 2117 doi: 10.2147/JHC.S436062
|
| 2 |
Liuqing Yang, Qiang Wang, Tingting Cui, Jinxin Huang, Hui Jin, Stefano Gitto. Reporting and Performance of Hepatocellular Carcinoma Risk Prediction Models: Based on TRIPOD Statement and Meta-Analysis. Canadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/9996358
|
| 3 |
Liting You, Juan Zhou, Zhaodan Xin, J Spencer Hauck, Feifei Na, Jie Tang, Xiaohan Zhou, Zichen Lei, Binwu Ying. Novel directions of precision oncology: circulating microbial DNA emerging in cancer-microbiome areas. Precision Clinical Medicine 2022; 5(1) doi: 10.1093/pcmedi/pbac005
|
| 4 |
C. Graf, G. Dultz. Therapie der Hepatitis C: Welche Problemkonstellationen gibt es noch?. Der Gastroenterologe 2021; 16(6): 442 doi: 10.1007/s11377-021-00566-8
|
| 5 |
Stefan Zeuzem. Treatment Options in Hepatitis C. Deutsches Ärzteblatt international 2017; doi: 10.3238/arztebl.2017.0011
|
| 6 |
Kyungtaek Im, Jisu Kim, Hyeyoung Min. Ginseng, the natural effectual antiviral: Protective effects of Korean Red Ginseng against viral infection. Journal of Ginseng Research 2016; 40(4): 309 doi: 10.1016/j.jgr.2015.09.002
|
| 7 |
Ragunath Barath, Kaviarasan Vaishak, Ramakrishnan Veerabathiran. Oncogenic Viruses. 2023; : 145 doi: 10.1016/B978-0-12-824152-3.00011-1
|
| 8 |
Hanan Omar, Samaa Taha, Wafaa Hassan, Hamdy Omar. Occult hepatitis B infection: a hidden factor of poor response to intervention treatment of hepatocellular carcinoma in chronic hepatitis C patients. Comparative Clinical Pathology 2018; 27(5): 1273 doi: 10.1007/s00580-018-2735-0
|
| 9 |
Yuanling Niu, Hao Kang, Pingyang Wang, Chenchen Guo, Fan Nie, Hongbin Ji, Jiarui Wu, Luonan Chen. Why Increase of Heterogeneity Signals Pre-Deterioration During Tumor Progression: A Unified Mathematical Model. SIAM Journal on Applied Mathematics 2023; 83(2): 791 doi: 10.1137/22M1497729
|
| 10 |
Angela Chau, Ming-Lun Yeh, Pei-Chien Tsai, Daniel Q. Huang, Sung Eun Kim, Huy Trinh, Eileen L. Yoon, Hyunwoo Oh, Jae Yoon Jeong, Sang Bong Ahn, Jihyun An, Cheng-Hao Tseng, Yao-Chun Hsu, Soung Won Jeong, Yong Kyun Cho, Jae-Jun Shim, Hyoung Su Kim, Takanori Ito, Sebastián Marciano, Keigo Kawashima, Takanori Suzuki, Tsunamasa Watanabe, Akito Nozaki, Toru Ishikawa, Kaori Inoue, Yuichiro Eguchi, Haruki Uojima, Hiroshi Abe, Hirokazu Takahashi, Makoto Chuma, Masatoshi Ishigami, Joseph K. Hoang, Mayumi Maeda, Chung-Feng Huang, Adrian Gadano, Chia-Yen Dai, Jee-Fu Huang, Yasuhito Tanaka, Wan-Long Chuang, Seng Gee Lim, Ramsey Cheung, Ming-Lung Yu, Dae-Won Jun, Mindie H. Nguyen. Sex Differences in Treatment Response to Nucleos(t)ide Therapy in Chronic Hepatitis B: A Multicenter Longitudinal Study. Clinical Gastroenterology and Hepatology 2024; 22(3): 572 doi: 10.1016/j.cgh.2023.09.002
|
| 11 |
Yen-Hao Chen, Chih-Chi Wang, Yen-Yang Chen, Jing-Houng Wang, Chao-Hung Hung, Yuan-Hung Kuo. Low-dose nivolumab in advanced hepatocellular carcinoma. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-10271-6
|
| 12 |
Uyen Mui, Christopher Haley, Stephen Tyring. Viral Oncology: Molecular Biology and Pathogenesis. Journal of Clinical Medicine 2017; 6(12): 111 doi: 10.3390/jcm6120111
|
| 13 |
Amy Lee, Fa-Chyi Lee. Medical oncology management of advanced hepatocellular carcinoma 2019: a reality check. Frontiers of Medicine 2020; 14(3): 273 doi: 10.1007/s11684-019-0728-2
|
| 14 |
Sahith Kudaravalli, Leslie Y. Kam, Daniel Q. Huang, Ramsey Cheung, Mindie H. Nguyen. Utilization of Antiviral Therapy for Patients With Hepatitis B–Related Hepatocellular Carcinoma: A Nationwide Real-World US Study. Clinical Gastroenterology and Hepatology 2023; 21(13): 3305 doi: 10.1016/j.cgh.2023.04.020
|
| 15 |
Derek J. Erstad, Allen A. Razavi, Shen Li, Kenneth K. Tanabe, Bryan C. Fuchs. Hepatocellular Carcinoma. Molecular and Translational Medicine 2019; : 255 doi: 10.1007/978-3-030-21540-8_13
|
| 16 |
Hou-Ying Cheng, Cheng-Maw Ho, Chih-Yang Hsiao, Ming-Chih Ho, Yao-Ming Wu, Po-Huang Lee, Rey-Heng Hu. Interval dynamics of transplantability for hepatocellular carcinoma after primary curative resection: risk factors for nontransplantable recurrence. HPB 2023; 25(2): 218 doi: 10.1016/j.hpb.2022.10.010
|